Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phage Therapy Center is a specialized medical facility based in Tbilisi, Georgia, dedicated to treating patients with severe, chronic, and antibiotic-resistant bacterial infections using bacteriophage therapy. The center leverages the historical expertise and vast phage collection of the Eliava Institute to provide personalized treatment plans for international patients. Their clinical approach involves identifying specific bacterial pathogens and selecting or adapting highly specific phages to eliminate the infection. Key treatment areas include MRSA, chronic prostatitis, urinary tract infections, and respiratory infections associated with cystic fibrosis. As one of the few centers worldwide offering this therapy clinically, it serves as a critical resource for patients who have exhausted conventional antibiotic options.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phage Therapy Center.